FGF-19 Antibodies

Santa Cruz Biotechnology delivers a wide array of FGF-19 monoclonal antibodies for research focused on understanding Fibroblast Growth Factor 19. FGF-19 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fibroblast Growth Factor 19 is a member of the FGF family and plays a crucial role in regulating bile acid synthesis and glucose metabolism. FGF-19 is involved in various physiological processes, including liver function and energy homeostasis, making it an important target for research in metabolic diseases and liver disorders. Understanding FGF-19 can provide insights into therapeutic strategies for conditions such as obesity and diabetes. Researchers worldwide utilize FGF-19 monoclonal antibodies to explore cellular pathways and molecular mechanisms. Advanced research techniques and protocols support comprehensive studies of FGF-19 expression and activity. Santa Cruz Biotechnology monoclonal antibodies for FGF-19 continue to advance scientific understanding of metabolic regulation and disease mechanisms.